Please enable Javascript
Conferences
Partners
Expert Interviews
Subscribe
Breast Cancers Today
HER2 Breast Cancer
HR Breast Cancer
Triple-Negative Breast Cancer
Genetics & Breast Cancer
Gastro Today
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Hepatitis
Heme Today
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Metabolic Care Today
Diabetes
Obesity
Nephrology Times
Acute Kidney Injury
ADPKD
Anemia and Kidney Disease
Chronic Kidney Disease
COVID-19 and Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Gout
Hyperkalemia
IgAN
Kidney Transplantation
Metabolic Acidosis
Sleep
More
Career News
Future of Medicine
Health and Wellness
— HIV
Infectious Diseases
Lupus
Neurology
Oncology
Ophthalmology
— Demodex Blepharitis
Orthopedics
Pharmacology
Pulmonology
Rheumatology
Urology
Dr. Gurleen Kaur
Articles by Dr. Gurleen Kaur
Lp(a) Therapeutics: A New Addition to the Armamentarium for ASCVD?
Dr. Gurleen Kaur
CardioNerds
|
July 10, 2025
Elevated lipoprotein(a) is an established risk factor for atherosclerotic cardiovascular disease.
Read More
The South Asian Cardiometabolic Curse: A High-Risk Population
Dr. Gurleen Kaur
CardioNerds
|
July 10, 2025
South Asian ethnicity is a risk-enhancing factor for atherosclerotic cardiovascular disease.
Read More
Personalized Physician Reminders Increase the Use of High-Intensity Statins in Patients with ASCVD
Dr. Gurleen Kaur
CardioNerds
|
April 14, 2025
While statins are a key pillar in the treatment of patients with any type of atherosclerotic cardiovascular disease ...
Listen Now